Keywords: |
clinical trial; review; animals; gene expression; tumor antigen; cellular immunity; molecular sequence data; immunotherapy; cancer vaccine; cancer vaccines; antibody response; antigen recognition; epitope; glycosylation; vaccine production; tumor vaccine; antibodies, neoplasm; intercellular adhesion molecule 1; t lymphocyte activation; ganglioside gd3; ganglioside gm2; antigens, tumor-associated, carbohydrate; carbohydrate sequence; carbohydrates; carbohydrate antigen; antibody production; antibody dependent cellular cytotoxicity; glycolipid; cancer antibody; edrecolomab; sialic acid; humans; human; priority journal; fucosylation
|